Diazald-d3
CAS: 42366-72-3
Ref. 3D-SBA36672
| 1g | Discontinued | ||
| 10mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
Diazald-d3
Synonyms:
- 4-Methyl-N-(methyl-d<sub>3</sub>)-N-nitrosobenzenesulfonamide
- Benzenesulfonamide, 4-methyl-N-(methyl-d<sub>3</sub>)-N-nitroso-
- Diazald(R)-N-Methyl-D3
- Diazald-N-Methyl-D3, 98 Atom % D
- Diazald?N-methyl-d3
- N-Methyl-D3-N-Nitroso-P-Toluenesulfonamide
- N-Methyl-N-Nitroso-P-Toluenesulfonamide (N-Methyl-D3)
- p-Toluenesulfonamide, N-methyl-d<sub>3</sub>-N-nitroso-
- 4-Methyl-N-(methyl-d3)-N-nitrosobenzenesulfonamide
- p-Toluenesulfonamide, N-methyl-d3-N-nitroso-
- See more synonyms
- Benzenesulfonamide, 4-methyl-N-(methyl-d3)-N-nitroso-
Description:
Diazald-d3 is a potent inhibitor of cancer cell growth and a promising medicinal compound for the treatment of various types of cancer. It targets human kinases involved in the regulation of the cell cycle, which are often overexpressed in tumor cells. Diazald-d3 has been shown to induce apoptosis and inhibit proliferation in several cancer cell lines, making it a potential anticancer agent. In addition, recent studies suggest that Diazald-d3 can be effectively delivered to cancer cells using nanoparticles, increasing its therapeutic potential. With its ability to target key proteins involved in cancer development and progression, Diazald-d3 represents a promising avenue for the development of novel cancer therapies.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
217.26 g/mol
Formula:
C8H10N2O3S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
